AR015733A1 - DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO. - Google Patents
DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO.Info
- Publication number
- AR015733A1 AR015733A1 ARP990101167A ARP990101167A AR015733A1 AR 015733 A1 AR015733 A1 AR 015733A1 AR P990101167 A ARP990101167 A AR P990101167A AR P990101167 A ARP990101167 A AR P990101167A AR 015733 A1 AR015733 A1 AR 015733A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- hydrogen atom
- lower alkyl
- integer
- derivative
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 9
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000002252 acyl group Chemical group 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000005333 aroyloxy group Chemical group 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004761 fibrosis Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003222 pyridines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C07D213/643—2-Phenoxypyridines; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Un derivado de la piridina representado por la formula (1) [donde R1 representa un átomo de halogeno o un grupo alquilo inferior sustituido con halogeno;R2 y R3 son iguales o distintos y representan un átomo de hidrogeno o un átomo de halogeno; Vrep resenta un grupo: -C(=O)-NH-, un grupo: -NH-C(=O)-, un grupo:-NH-C(=O)-NH- o un grupo: -CH = CH-; A representa un grupo de formula A1, donde R4 representa un átomo de hidrogeno, un grupo alcanoilo inferior, un grupobenceno, un grupo 2-alquiloinferio r-1,3 dioxolano o un grupo alquilo inferior sustituido con hidroxi; R5 representa un átomo de hidrogeno, un grupo 2 -alquilo inferior -1,3 dioxolano, un grupo alquilo inferior o un grupo alcanoilo inferior; y R6 representa un átomo dehidrogeno, un g rupo alquilo inferior o ungrupo alcanoilo inferior; un grupo de formula A2 donde R7 representa un átomo de hidrogeno o un grupo alquilo inferior; y R8 puede ser igual o distinto yrepresenta un átomo de hidrogeno, un grupo hidroxilo,un grupo oxo, un grupo alcanoiloxi inferior, un grupo aroiloxi, un grupo alcoxi inferior, un grupo (II)donde k representa un entero de 1 a 3 o un grupo: =N-OR10 (R10 representa un átomo de hidrogeno, un grupo alquilo inferior o un grupo alcanoiloinferior); prepresen ta un entero de 1 a 2; la línea punteada representa un enlace doble opcional; y representa un grupo: -(CH2)m-, un grupo: =CH(CH2)m -1- o un grupo:-(CH2)m - 1 CH=; y m representa un entero de 1 a 3) o un grupo A3: (donde R9 puedeser igual o diferente y representa un átomo de hidrogeno, un grupohidroxilo, un grupo oxo, un grupo alcanoiloxi inferior, un grupo aroiloxi, un grupo alcoxi inferior, un grupo de la formula III donde k representa un entero de1 a 3 o un grupo: -N-OR10 (R10 representa un átomo de hidrogeno, un grupo alquilo inferior o un grupo alcanoilo inferior); q representa un entero de 1 a 2; lalínea punteada representa un enlace simple o un enlace doble; z representa un grupo: (CH2)n-, un grupo: -(CH2)n-1 - o un grupo -(CH2)n-1 CH= ; y unrepresenta un entero de 1 a 3)] o una sal de estos, (II) una composicion farmacéutica para profilaxis o tratamiento de fibrosis que contiene un compuesto de la
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7808398 | 1998-03-25 | ||
| JP25155298 | 1998-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015733A1 true AR015733A1 (es) | 2001-05-16 |
Family
ID=26419157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101167A AR015733A1 (es) | 1998-03-25 | 1999-03-17 | DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6511995B1 (es) |
| EP (1) | EP1066261B1 (es) |
| JP (1) | JP4386579B2 (es) |
| KR (1) | KR100365063B1 (es) |
| CN (1) | CN1115334C (es) |
| AR (1) | AR015733A1 (es) |
| AT (1) | ATE310726T1 (es) |
| AU (1) | AU759969B2 (es) |
| BR (1) | BR9909024B1 (es) |
| CA (1) | CA2322953C (es) |
| DE (1) | DE69928509T2 (es) |
| DK (1) | DK1066261T3 (es) |
| ES (1) | ES2251827T3 (es) |
| HK (1) | HK1036273A1 (es) |
| ID (1) | ID27479A (es) |
| MY (1) | MY125650A (es) |
| TW (1) | TW585856B (es) |
| WO (1) | WO1999048871A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000027A (es) * | 1998-08-19 | 1999-06-02 | Bayer Ip Gmbh | Arilsulfonamidas y analagos |
| EP1150955A2 (en) * | 1999-02-04 | 2001-11-07 | Millennium Pharmaceuticals, Inc. | G-protein coupled heptahelical receptor binding compounds and methods of use thereof |
| MX2007001215A (es) * | 2004-08-06 | 2007-04-17 | Otsuka Pharma Co Ltd | Compuestos aromaticos. |
| ZA200804445B (en) | 2005-12-05 | 2009-11-25 | Otsuka Pharma Co Ltd | Diarylether derivatives as antitumor agents |
| UA95978C2 (ru) | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
| ITRM20070088A1 (it) * | 2007-02-19 | 2008-08-20 | Francesco Fringuelli | Composti derivati della colchicina, procedimento per la loro preparazione e usi in campo medico. |
| TWI440638B (zh) * | 2007-10-30 | 2014-06-11 | Otsuka Pharma Co Ltd | 雜環化合物及其藥學組成物 |
| JP5688918B2 (ja) * | 2009-04-28 | 2015-03-25 | 大塚製薬株式会社 | 医薬組成物 |
| US8722695B2 (en) | 2009-12-11 | 2014-05-13 | Autifony Therapeutics Limited | Imidazolidinedione derivatives |
| MY160875A (en) * | 2010-01-29 | 2017-03-31 | Otsuka Pharma Co Ltd | Di-substituted pyridine derivatives as anticancers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW352384B (en) | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
| US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
-
1999
- 1999-03-17 AR ARP990101167A patent/AR015733A1/es active IP Right Grant
- 1999-03-19 ES ES99909286T patent/ES2251827T3/es not_active Expired - Lifetime
- 1999-03-19 DE DE69928509T patent/DE69928509T2/de not_active Expired - Lifetime
- 1999-03-19 KR KR1020007010516A patent/KR100365063B1/ko not_active IP Right Cessation
- 1999-03-19 WO PCT/JP1999/001425 patent/WO1999048871A1/en active IP Right Grant
- 1999-03-19 DK DK99909286T patent/DK1066261T3/da active
- 1999-03-19 CA CA002322953A patent/CA2322953C/en not_active Expired - Fee Related
- 1999-03-19 EP EP99909286A patent/EP1066261B1/en not_active Expired - Lifetime
- 1999-03-19 BR BRPI9909024-4A patent/BR9909024B1/pt not_active IP Right Cessation
- 1999-03-19 AT AT99909286T patent/ATE310726T1/de not_active IP Right Cessation
- 1999-03-19 AU AU28544/99A patent/AU759969B2/en not_active Ceased
- 1999-03-19 CN CN99804271A patent/CN1115334C/zh not_active Expired - Fee Related
- 1999-03-19 US US09/646,935 patent/US6511995B1/en not_active Expired - Fee Related
- 1999-03-19 MY MYPI99001052A patent/MY125650A/en unknown
- 1999-03-19 JP JP2000537854A patent/JP4386579B2/ja not_active Expired - Lifetime
- 1999-03-19 ID IDW20001911A patent/ID27479A/id unknown
- 1999-03-25 TW TW088104708A patent/TW585856B/zh not_active IP Right Cessation
-
2001
- 2001-09-20 HK HK01106636A patent/HK1036273A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK1066261T3 (da) | 2006-01-30 |
| DE69928509D1 (de) | 2005-12-29 |
| WO1999048871A1 (en) | 1999-09-30 |
| CA2322953C (en) | 2009-05-05 |
| MY125650A (en) | 2006-08-30 |
| EP1066261A1 (en) | 2001-01-10 |
| AU2854499A (en) | 1999-10-18 |
| ID27479A (id) | 2001-04-12 |
| BR9909024B1 (pt) | 2010-05-18 |
| KR100365063B1 (ko) | 2002-12-18 |
| KR20010034628A (ko) | 2001-04-25 |
| BR9909024A (pt) | 2000-12-05 |
| DE69928509T2 (de) | 2006-08-10 |
| ATE310726T1 (de) | 2005-12-15 |
| CA2322953A1 (en) | 1999-09-30 |
| ES2251827T3 (es) | 2006-05-01 |
| US6511995B1 (en) | 2003-01-28 |
| TW585856B (en) | 2004-05-01 |
| HK1036273A1 (en) | 2001-12-28 |
| EP1066261B1 (en) | 2005-11-23 |
| CN1115334C (zh) | 2003-07-23 |
| JP2002507601A (ja) | 2002-03-12 |
| JP4386579B2 (ja) | 2009-12-16 |
| CN1294581A (zh) | 2001-05-09 |
| AU759969B2 (en) | 2003-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA39869C2 (uk) | Похідні аспартаму або їх фізіологічно прийнятні солі, спосіб їх отримання та підсолоджувальна композиція | |
| MX9602837A (es) | Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados. | |
| ATE203515T1 (de) | Meta-substituierte phenylsulphonamidderivate | |
| AR015733A1 (es) | DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO. | |
| CY1273A (en) | 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates | |
| ATE346850T1 (de) | 5-ht4-rezeptor-antagonisten | |
| ATE122669T1 (de) | Zearalanol-derivate mit anabolytischer wirkung. | |
| NZ240441A (en) | Thiazol- or thiadiazol-substituted 7-acyl-3-substituted carbamoyloxy cephem derivatives and antibacterial compositions thereof; cephem intermediates | |
| ATE285771T1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
| IL81733A0 (en) | Penem derivatives,their preparation and pharmaceutical compositions containing them | |
| ES8506011A1 (es) | Procedimiento para la obtencion de un derivado de tetrahidrobenzotiazol | |
| PT90291A (pt) | Processo para a preparacao de compostos afins das avermectinas uteis como agentes antiparasiticos | |
| NO872982L (no) | Nye tetracykliske indolderivater. | |
| DK0528209T3 (da) | Fremgangsmåde til fremstilling af mellemprodukter til D-Vitaminderivater og nye forbindelser | |
| DE69528984T2 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| EA200000922A1 (ru) | Производные аминоантрациклинона и их применение в лечении амилоидоза |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |